Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 DHA And ARA Supplemented Infant Formulas To Launch In U.S. - Nutraceuticals World
Market Updates

DHA And ARA Supplemented Infant Formulas To Launch In U.S.

DHA And ARA Supplemented Infant Formulas To Launch In U.S.
In the coming months several companies will be launching the first infant formulas enriched with DHA (docosahexaenoic acid) and ARA (arachidonic acid) into the U.S. market. While formulas supplemented with these polyunsaturated fatty acids (PUFAs) have been available in more than 60 countries for several years, this is the first time FDA has approved their use for this purpose. The first company to launch an infant formula product supplemented with the aforementioned components is Mead Johnson Nutritionals, Evansville, IN. Mead Johnson is introducing its new infant formula supplemented with a proprietary formula of DHA and ARA oils produced by Martek Biosciences, Columbia, MD. The new product, Enfamil LIPIL™, was slated to hit store shelves in February.
In related news, plans are also underway at the Ross Products Division of Abbott Laboratories, Columbus, OH, to launch an infant formula with Martek’s DHA and ARA oils. The U.S. launch is set to take place early this year.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters